Compared with western medicine, there are many complicated factors affecting the intrinsic quality of traditional Chinese medicine, because its production needs to be planted, harvested, processed, transported, stored...Compared with western medicine, there are many complicated factors affecting the intrinsic quality of traditional Chinese medicine, because its production needs to be planted, harvested, processed, transported, stored, and sold, etc. Therefore, the internet of things is integrated into the traceability of traditional Chinese medicine, and its key technologies are studied. An XMLbased traceability information exchange model was constructed for traditional Chinese medicine and modeled the traceability process by the finite state machine (FSM). Furthermore, the specific electronic product code (EPC) coding scheme of traditional Chinese medicine was proposed based on the EPC coding structure model. Finally, the effectiveness of the above models and schemes is verified by an example of a traditional Chinese medicine traceability prototype system.展开更多
背景:NOD样受体热蛋白结构域相关蛋白3(NOD-like receptor thermal protein domain associated protein 3,NLRP3)炎性小体与脊髓损伤后的神经炎症密切相关,小胶质细胞极化和焦亡在其中发挥关键作用,靶向调控NLRP3有利于诱导小胶质细胞...背景:NOD样受体热蛋白结构域相关蛋白3(NOD-like receptor thermal protein domain associated protein 3,NLRP3)炎性小体与脊髓损伤后的神经炎症密切相关,小胶质细胞极化和焦亡在其中发挥关键作用,靶向调控NLRP3有利于诱导小胶质细胞从M1促炎表型向M2抗炎表型极化和调节小胶质细胞焦亡,是一个有前景的治疗策略。目的:归纳NLRP3炎性小体在脊髓损伤后小胶质细胞中作用的分子机制以及治疗策略的研究进展。方法:检索PubMed、Web of Science和中国知网数据库,英文检索词为“spinal cord injury,NLRP3,microglia,polarization,pyroptosis”,中文检索词为“脊髓损伤,NLRP3,小胶质细胞,极化,焦亡,炎症”,按纳入和排除标准共纳入79篇文献进行总结。结果与结论:①目前,关于脊髓损伤复杂的发病机制尚未有统一定论,大量研究表明脊髓损伤与炎症因子和信号通路关系密切,以NLRP3炎性小体作为其发病机制和治疗突破口的相关研究也是当前的热点。②NLRP3炎性小体在脊髓损伤后的炎症反应、氧化应激和神经元恢复等起到关键作用。③小胶质细胞是脑和脊髓中的免疫细胞,是继发性脊髓损伤最重要的调节因子,脊髓损伤后小胶质细胞对内部环境作出调整,主要表现为极化及焦亡,产生大量炎症因子,阻碍脊髓损伤的神经再生和功能恢复,通过调控小胶质细胞表型变化,是治疗脊髓损伤的另一个关键因素。④NLRP3炎性小体与小胶质细胞密切相关,脊髓损伤后NLRP3炎性小体主要在小胶质细胞中表达,其会促进小胶质细胞向M1极化和促进促裂解蛋白D的产生,进一步破坏神经稳态,从而加重脊髓损伤的进展。⑤许多分子参与NLRP3炎性小体调控小胶质细胞,其中核转录因子κB及MAPK信号通路促进NLRP3炎性小体表达,其他信号通路抑制该炎性小体表达。⑥目前有大量的外源性分子及药物调控NLRP3炎性小体,临床应用前景广泛,已有相关药物处于临床试验阶段并取得良好疗效,如NLRP3特异性抑制剂MCC950,但如何精准控制靶向递送、减少对其他组织器官影响等关键问题亟需解决,随着研究的深入,未来有望在脊髓损伤治疗方式上作出新的突破。展开更多
基金the Natural Science Foundation of China (Grant No. 61701005)the Domestic Visiting Research Project of Excellent Young Backbone Talents from Anhui Higher Education Institutions (Grant No. gxgnfx2019009)+6 种基金the Key Project of Humanities and Social Sciences Research in Anhui Higher Education Institutions in 2019 (Grant No. SK2019A0242)the Quality Project Foundation of Anhui Province (Grant No. 2017mooc220, No. 2018zhkt079, No. 2015sxzx011, No. 2012sjjd025)the Key Project of Outstanding Young Talents Support Program of Anhui Higher Education Institutions (Grant No. gxyqZD2016128)the Key Project of Natural Science Research in Anhui Higher Education Institutions (Grant No. KJ2015A054, No. KJ2019A0437)the Key Teaching and Research Project of Anhui University of Chinese Medicine (Grant No. 2017xjjy_zd011)the Natural Science key Foundation of Anhui University of Chinese Medicine (Grant No. 2019zrzd11, No. 2018zryb06)the National Innovation and Entrepreneurship Training Program for College Student (Grant No. 20181036 9021, No. 201810369022, No. 201610369044, No. 201710369052).
文摘Compared with western medicine, there are many complicated factors affecting the intrinsic quality of traditional Chinese medicine, because its production needs to be planted, harvested, processed, transported, stored, and sold, etc. Therefore, the internet of things is integrated into the traceability of traditional Chinese medicine, and its key technologies are studied. An XMLbased traceability information exchange model was constructed for traditional Chinese medicine and modeled the traceability process by the finite state machine (FSM). Furthermore, the specific electronic product code (EPC) coding scheme of traditional Chinese medicine was proposed based on the EPC coding structure model. Finally, the effectiveness of the above models and schemes is verified by an example of a traditional Chinese medicine traceability prototype system.
文摘背景:NOD样受体热蛋白结构域相关蛋白3(NOD-like receptor thermal protein domain associated protein 3,NLRP3)炎性小体与脊髓损伤后的神经炎症密切相关,小胶质细胞极化和焦亡在其中发挥关键作用,靶向调控NLRP3有利于诱导小胶质细胞从M1促炎表型向M2抗炎表型极化和调节小胶质细胞焦亡,是一个有前景的治疗策略。目的:归纳NLRP3炎性小体在脊髓损伤后小胶质细胞中作用的分子机制以及治疗策略的研究进展。方法:检索PubMed、Web of Science和中国知网数据库,英文检索词为“spinal cord injury,NLRP3,microglia,polarization,pyroptosis”,中文检索词为“脊髓损伤,NLRP3,小胶质细胞,极化,焦亡,炎症”,按纳入和排除标准共纳入79篇文献进行总结。结果与结论:①目前,关于脊髓损伤复杂的发病机制尚未有统一定论,大量研究表明脊髓损伤与炎症因子和信号通路关系密切,以NLRP3炎性小体作为其发病机制和治疗突破口的相关研究也是当前的热点。②NLRP3炎性小体在脊髓损伤后的炎症反应、氧化应激和神经元恢复等起到关键作用。③小胶质细胞是脑和脊髓中的免疫细胞,是继发性脊髓损伤最重要的调节因子,脊髓损伤后小胶质细胞对内部环境作出调整,主要表现为极化及焦亡,产生大量炎症因子,阻碍脊髓损伤的神经再生和功能恢复,通过调控小胶质细胞表型变化,是治疗脊髓损伤的另一个关键因素。④NLRP3炎性小体与小胶质细胞密切相关,脊髓损伤后NLRP3炎性小体主要在小胶质细胞中表达,其会促进小胶质细胞向M1极化和促进促裂解蛋白D的产生,进一步破坏神经稳态,从而加重脊髓损伤的进展。⑤许多分子参与NLRP3炎性小体调控小胶质细胞,其中核转录因子κB及MAPK信号通路促进NLRP3炎性小体表达,其他信号通路抑制该炎性小体表达。⑥目前有大量的外源性分子及药物调控NLRP3炎性小体,临床应用前景广泛,已有相关药物处于临床试验阶段并取得良好疗效,如NLRP3特异性抑制剂MCC950,但如何精准控制靶向递送、减少对其他组织器官影响等关键问题亟需解决,随着研究的深入,未来有望在脊髓损伤治疗方式上作出新的突破。
文摘目的研究辛前甘桔汤对慢性鼻窦炎(CRS)小鼠长链非编码RNA小核仁RNA宿主基因16(lnc RNA SNHG16)、表皮生长因子受体(EGFR)及黏蛋白5AC(MUC5AC)m RNA表达的影响。方法36只C57BL/6小鼠随机分为正常组、模型组、羧甲司坦组及辛前甘桔汤低、中、高剂量组,每组6只。采用金黄色葡萄球菌鼻腔灌注建立小鼠CRS模型。正常组与模型组小鼠灌胃质量分数为0.9%的氯化钠溶液(0.6 g·kg^(-1)·d^(-1)),辛前甘桔汤低、中、高剂量组分别灌胃辛前甘桔汤水煎液(0.3、0.6、1.2 g·kg^(-1)·d^(-1)),羧甲司坦组灌胃羧甲司坦口服液(0.3 m L·kg^(-1)·d^(-1)),连续干预14 d。采用苏木精-伊红(HE)及阿尔新蓝-过碘酸雪夫(AB-PAS)染色法观察小鼠鼻黏膜结构,免疫组织化学法观察小鼠鼻黏膜EGFR、MUC5AC表达并测量光密度值;酶联免疫吸附试验(ELISA)检测样本中白介素-6(IL-6)、白介素-8(IL-8)、基质金属蛋白酶-9(MMP-9)水平。实时荧光定量逆转录聚合酶链式反应(RT-q PCR)检测样本中lnc RNA SNHG16、EGFR、MUC5AC m RNA的表达。结果与正常组比较,模型组鼻黏膜上皮结构紊乱,IL-6、IL-8、MMP-9含量明显升高(P<0.05),lnc RNA SNHG16、EGFR、MUC5AC m RNA表达明显升高(P<0.05)。与模型组比较,辛前甘桔汤各剂量组IL-6水平显著降低(P<0.05),辛前甘桔汤中、高剂量组MMP-9、IL-8水平降低(P<0.05),辛前甘桔汤各剂量组lnc RNA SNHG16、EGFR、MUC5AC m RNA表达显著降低(P<0.05)。与羧甲司坦组比较,辛前甘桔汤高剂量组lnc RNA SNHG16、EGFR m RNA表达降低(P<0.05)。结论辛前甘桔汤能降低lnc RNA SNHG16、EGFR、MUC5AC m RNA表达,降低EGFR、MUC5AC蛋白表达,减少IL-6、IL-8、MMP-9表达,进而改善鼻黏膜病理改变。